Is 1000mg of Keflex TID for 5 Days Appropriate for Cellulitis?
No, this regimen is suboptimal—the dose is reasonable but the frequency should be four times daily (QID) and the duration should be 7-10 days, not 5 days.
Dosing Frequency and Total Daily Dose
The FDA-approved dosing for cephalexin in skin and soft tissue infections specifies 500 mg every 12 hours OR 250 mg every 6 hours for uncomplicated cases 1. For more severe infections, the label explicitly states "larger doses may be needed" with a maximum of 4 grams daily in divided doses 1. Your proposed 1000 mg TID provides 3 grams daily, which falls within the acceptable range.
However, recent evidence suggests that higher doses given four times daily may be more effective:
- A 2023 pilot RCT comparing high-dose (1000 mg QID) versus standard-dose (500 mg QID) cephalexin found treatment failure in only 3.2% of high-dose patients versus 12.9% in standard-dose patients 2
- A 2022 pediatric study using high-dose oral cephalexin achieved an 89.7% success rate for moderate cellulitis 3
The three-times-daily (TID) dosing is problematic because cephalexin's pharmacokinetics favor more frequent dosing intervals. The FDA label consistently recommends divided doses throughout the day, typically every 6-12 hours 1.
Duration of Therapy
Five days is too short for cellulitis treatment. The FDA label does not specify a minimum duration for skin infections, but the IDSA guidelines emphasize that β-hemolytic streptococcal infections require "at least 10 days" of therapy 4. In clinical practice:
- Most RCTs evaluating cellulitis treatment use 7-day courses as the standard 2, 5
- The 2023 high-dose cephalexin trial used 7 days 2
- For streptococcal infections specifically, 10 days is recommended to prevent complications 4
A 7-10 day course is the evidence-based standard, with 7 days being acceptable for uncomplicated cases and 10 days preferred when streptococcal etiology is suspected.
Recommended Regimen
For uncomplicated non-purulent cellulitis, prescribe cephalexin 500 mg four times daily (QID) for 7 days, or consider 1000 mg QID for more severe presentations, extending to 10 days if streptococcal infection is likely.
Key Clinical Considerations:
- Pathogen coverage: Non-purulent cellulitis is predominantly caused by β-hemolytic streptococci and methicillin-sensitive S. aureus 6. Cephalexin provides appropriate coverage without needing MRSA-active agents 5
- MRSA coverage is generally unnecessary: A large RCT found no benefit to adding trimethoprim-sulfamethoxazole to cephalexin for uncomplicated cellulitis 5
- Treatment failure rates: Expect approximately 10-15% treatment failure with standard cephalexin regimens 2, 5
Common Pitfalls to Avoid:
- Insufficient duration: Five days risks treatment failure and potential complications, particularly with streptococcal infections
- Suboptimal frequency: TID dosing may result in subtherapeutic drug levels during the longer intervals between doses
- Misdiagnosis: Remember that 80% of cellulitis cases lack microbiological confirmation 4, and pseudocellulitis (venous stasis dermatitis, contact dermatitis) is commonly misdiagnosed as infection 6
The evidence strongly supports cephalexin 500 mg QID for 7-10 days as the standard approach, with consideration of 1000 mg QID for more severe cases based on emerging data 1, 2.